Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × sacituzumab govitecan × Clear all

NCT07339059 2026-01-30

SG and Immunotherapy as Maintenance Therapy for Extensive-stage Small-cell Lung Cancer

Phase 2 Recruiting

Lung Neoplasms, Small Cell Lung Carcinoma